A modest one-day dip of around 1.7% has put Genedrive (LSE:GDR) back on the radar of traders who follow the more speculative end of the UK diagnostics sector. A move of that scale, on subdued volume, is well within the day-to-day noise for a …
A decline of just under 4% in Thalia Therapeutics (LSE:THAT) is the sort of move that, in a small health-technology stock, tends to reflect the character of the market it trades in rather than any confirmed piece of news. In lightly traded life-sciences names, …
Poolbeg Pharma (LSE:POLB) tends to move in the way small clinical-stage biotechs often do: in sharp, sentiment-driven steps that can look dramatic against a modest share price. The latest session saw the shares fall around 4.4%, but the move arrived on subdued trading volume …
Genflow Biosciences (LSE:GENF) is a stock that sits at the speculative end of the market, and its shares tend to move accordingly. In the latest session the price eased around 2.3%, but the decline came on extremely thin volume and without any accompanying company …
BioPharma Credit PLC — LSE:BPCR closed 0.89% higher on07 September 2026, with the shares at 71.22p after a gain of 0.63p on the day.
CT Healthcare Trust PLC — LSE:CTHT closed 0.30% lower on07 September 2026, with the shares at 132.00p after a loss of 0.40p on the day.
A rise of 0.33% in Applied Nutrition (LSE:APN) is barely a move at all in market terms, and no specific announcement was apparent to account for it. For a company of Applied Nutrition's size and profile, a change of this magnitude falls well within …
GENinCode (LSE:GENI) surged, the shares jumping sharply in a session that marked a clear break from the drift that so often characterises small precision-medicine stocks. The move followed a company announcement relating to a milestone for its CARDIO inCode-Score product, an update that put …
Oxford BioDynamics (LSE:OBD) has drawn a flicker of trading interest after its shares moved close to 6% higher, a jump large enough in percentage terms to catch the eye of momentum-watchers even though the epigenetics group remains one of the smaller and more speculative …
AstraZeneca Plc — LSE:AZN closed 0.10% higher on04 September 2026, with the shares at 12,158.00p after a gain of 12.00p on the day.